U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07641517) titled 'A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain' on June 08.
Brief Summary: The main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Osteoarthritis, Knee
Chronic Pain
Intervention:
DRUG: LY4065967
Administered orally
DRUG: Placebo
Administered orally
Recruitme...